Verrica Pharmaceuticals VRCA Declines 19 Approaches Critical Support at 562 Friday Intraday Session Information Technology Stocks Experience Notable Movements WEAV Q1 2026 Earnings Profitability Beat Drives Stock Higher The AI Economy Shifts Focus BlueCollar Skilled Trades Gain as EntryLevel College Roles Slow